Indaptus Therapeutics raised $5.7 million through the sale of convertible promissory notes and warrants for R&D purposes. Indaptus Therapeutics, Inc., a clinical stage biotech company, announced the ...
VANCOUVER, BC / ACCESS Newswire / December 3, 2025 / Golden Lake Exploration Inc. ("Golden Lake" or the "Company") (CSE:GLM)(OTC PINK:GOLXF) announces that it has entered into an unsecured, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback